Tredje AP-fonden’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-271,999	Closed	-$16.2M	–	557
2025 Q4	$16.2M	Sell	271,999 -24,940	-8%	-$1.36M	0.12%	127
2025 Q3	$16.1M	Buy	296,939 +6,197	+2%	+$354K	0.13%	124
2025 Q2	$16M	Buy	290,742 +4,078	+1%	+$240K	0.13%	111
2025 Q1	$20.3M	Buy	286,664 +63,000	+28%	+$4.24M	0.19%	105
2024 Q4	$14.7M	Buy	223,664 +194,334	+663%	+$13M	0.13%	128
2024 Q3	$2.06M	Hold	29,330	–	–	0.02%	362
2024 Q2	$2.41M	Sell	29,330 -463	-2%	-$38.5K	0.02%	320
2024 Q1	$2.6M	Hold	29,793	–	–	0.03%	320
2023 Q4	$2.87M	Sell	29,793 -1,185	-4%	-$105K	0.04%	298
2023 Q3	$2.74M	Sell	30,978 -2,883	-9%	-$257K	0.04%	293
2023 Q2	$2.94M	Sell	33,861 -5,547	-14%	-$522K	0.04%	301
2023 Q1	$3.83M	Buy	39,408 +1,914	+5%	+$198K	0.06%	233
2022 Q4	$3.88M	Sell	37,494 -239	-0.6%	-$22.4K	0.07%	214
2022 Q3	$3.2M	Buy	+37,733	New	+$3.36M	0.07%	221